Clinical trials
Recruiting Phase 1/2 Burkitt Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| AstraZeneca | 2 |
| Liping Dou | 2 |
| M.D. Anderson Cancer Center | 2 |
| Stephan Grupp MD PhD | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beijing Biotech | 1 |
| Cellectis S.A. | 1 |
| Excyte Biopharma Ltd | 1 |
| Juventas Cell Therapy Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 22 |
| Recurrence | 6 |
| Lymphoma | 4 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Follicular | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.